oncology

Roche’s Tiragolumab Faces Setback in Lung Cancer Trial, failing to show survival benefit in Phase III study, raising treatment concerns.

Study Finds Many Canadians Visit ER Before Receiving Cancer Diagnosis, with over half hospitalized and certain groups more likely to seek urgent care.